Monoclonal Gammopathy in Sézary Syndrome
Authors:
- Pierre Y. VenenciePVPierre Y. Venencie
- R. K. WinkelmannRWR. K. Winkelmann
- A. PuissantAPA. Puissant
- Robert A. KyleRKRobert A. Kyle
- 1 May 1984
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 120 (5) , 605-608
Abstract
From JAMA Dermatology — Monoclonal Gammopathy in Sézary Syndrome — Report of Three Cases and Review of the LiteratureKeywords
This publication has 8 references indexed in Scilit:
- Plasma cell myeloma in a patient with a cutaneous T-cell lymphomaCancer, 1982
- Suppressor cell population in Sézary syndromeClinical Immunology and Immunopathology, 1979
- Monoclonal gammopathy of undetermined significance. Natural history in 241 casesThe American Journal of Medicine, 1978
- Current Problems in Mycosis Fungoides and Sezary SyndromeAnnual Review of Medicine, 1977
- The Frequency of M-components in Sera of Patients with Solid Malignant NeoplasmsBritish Journal of Cancer, 1973
- PATHOLOGIC CONDITIONS ASSOCIATED WITH PLASMA CELL DYSCRASIAS: A STUDY OF 806 CASES *Annals of the New York Academy of Sciences, 1971
- Monoclonal gammopathy in human neoplasiaCancer, 1968
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966